leadf
logo-loader
viewProactive Australia

Southern Cannabis Holdings to present at medical cannabis webinar on Tuesday

The multinational company builds, integrates and operates businesses in pharmaceutical cannabis markets.

Southern Cannabis Holdings to present at medical cannabis webinar on Tuesday
The webinar is on August 11 at 12pm AEST

Southern Cannabis Holdings’ director and chief executive officer Tim Drury is set to present at Proactive’s medical cannabis virtual investor conference on Tuesday, August 11 at 12pm AEST (10am AWST).

Drury will outline the company’s plans to build, integrate and operate high value brands domestically and globally across the cannabis value chain.

These include:

  • Cannabis Access Clinics - Australia’s first and largest network of medicinal cannabis clinics;
  • Applied Cannabis Research - A specialist contract research organisation dedicated to assisting medicinal cannabis companies; and
  • FreshLeaf Analytics - Australia’s leading source of data and information about the medicinal cannabis industry.

Southern Cannabis Holdings’ director and chief executive officer Tim Drury

Three companies to present

MGC Pharmaceuticals Ltd (ASX:MXC) co-founder and managing director Roby Zomer will also present at the event, along with Zelira Therapeutics (ASX:ZLD) managing director and CEO Richard Hopkins.

The companies will discuss on the global medical cannabis, which is predicted to grow at a compound annual growth rate (CAGR) of 15.4% from 2019 to 2025, and is expected to be worth US$52.35 billion by 2025, according to Market Research Future (MRFR).

Webinar registration

To register for the August 11 webinar, please click here.

The webinar will also be live-streamed on the Proactive YouTube channel, which can then be viewed at any time following the presentation.

For additional information, please contact John Phillips at Proactive: john.phillips@proactiveinvestors.com or 0431 597 771.

Quick facts: Proactive Australia

Price: - -

ASX:.
Market: ASX
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Open Orphan first half: 'period of integration, restructuring and setting...

Proactive Analyst Emma Ulker talks through how Open Orphan (LON:ORPH) performed in the first half of the year.  In the six-month period to June 2020, the company focused on integration and restructuring following its acquisition of lab services and challenge studies specialist hVIVO in...

1 day, 10 hours ago

2 min read